A patient who is a 5-year breast cancer survivor, received doxorubicin, cyclophosphamide, paclitaxel, trastuzumab and pertuzumab. The patient now reports dyspnea, orthopnea, rapid weight gain, and edema of the ankles and feet. The nurse suspects: endocarditis, heart failure
[Expert Solution]: A patient who is a 5-year breast cancer…
Need help with your Cardiovascular Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.